{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:08:33Z","timestamp":1788973713428,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2240"],"award-info":[{"award-number":["FOR2240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO4489\/1-1"],"award-info":[{"award-number":["BO4489\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO4489\/1\\u20132"],"award-info":[{"award-number":["BO4489\/1\\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO4489\/3-1"],"award-info":[{"award-number":["BO4489\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008001","name":"Universit\u00e4t zu K\u00f6ln","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009983","name":"University of Cologne Center for Molecular Medicine Cologne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.exer.2025.110652","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T06:46:36Z","timestamp":1758869196000},"page":"110652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Promotion of vessel regression by local VEGF-A blockade improves the survival rate of corneal transplants"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-1697","authenticated-orcid":false,"given":"Zhe","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Mestanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110652_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/ijo.IJO_418_18","article-title":"Treatment of corneal neovascularization with topical aflibercept in a case of exposure keratopathy following cerebellar astrocytoma surgery","volume":"67","author":"Aksoy","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110652_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","article-title":"Promotion of graft survival by vascular endothelial growth factor A neutralization after high-risk corneal transplantation","volume":"126","author":"Bachmann","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":"Bevacizumab (Avastin) eye drops inhibit corneal neovascularization","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib5","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2008.08.007","article-title":"Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts","volume":"87","author":"Bock","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110652_bib7","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.4049\/jimmunol.1201531","article-title":"Topical application of soluble CD83 induces Ido-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival","volume":"191","author":"Bock","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2025.110652_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41698-021-00197-w","article-title":"Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients","volume":"5","author":"Boucher","year":"2021","journal-title":"npj Precis. Onc."},{"key":"10.1016\/j.exer.2025.110652_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4049\/jimmunol.182.1.148","article-title":"Levels of Foxp3 in regulatory T cells Reflect their functional status in transplantation","volume":"182","author":"Chauhan","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2025.110652_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11912-013-0368-7","article-title":"Aflibercept\u2014a Decoy VEGF Receptor","volume":"16","author":"Ciombor","year":"2014","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.exer.2025.110652_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101157","article-title":"The novel role of lymphatic vessels in the pathogenesis of ocular diseases","volume":"96","author":"Clahsen","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2025.110652_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":"Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation","volume":"87","author":"Cursiefen","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110652_bib14","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2025.110652_bib16","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","article-title":"Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival","volume":"51","author":"Dastjerdi","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib17","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s11033-021-06341-w","article-title":"The effect of aflibercept and arsenic trioxide on the proliferation, migration and apoptosis of oral squamous cell carcinoma in vitro","volume":"48","author":"Derakhshan","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.exer.2025.110652_bib18","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/2326-6066.CIR-18-0865","article-title":"Tumor vessel normalization, immunostimulatory reprogramming, and improved survival in glioblastoma with combined inhibition of PD-1, angiopoietin-2, and VEGF","volume":"7","author":"Di Tacchio","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.exer.2025.110652_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/jcm9020586","article-title":"Variable responses to corneal grafts: insights from immunology and systems biology","volume":"9","author":"Di Zazzo","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.exer.2025.110652_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2022.03.024","article-title":"Bevacizumab in high-risk corneal transplantation","volume":"129","author":"Dohlman","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110652_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/TP.0000000000000512","article-title":"VEGF-Trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation","volume":"99","author":"Dohlman","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.exer.2025.110652_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100492","article-title":"Suppression of neovascularization by topical and subconjunctival bevacizumab after high-risk corneal transplantation","volume":"4","author":"Dohlman","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjophthalmol-2014-304891","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"98","author":"Faraj","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-014-9938-4","article-title":"Subconjunctival and\/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival","volume":"35","author":"Fasciani","year":"2015","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.671.65.3","article-title":"Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies","volume":"65","author":"Gerber","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2025.110652_bib26","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.exer.2025.110652_bib27","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1167\/iovs.13-12460","article-title":"Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo","volume":"54","author":"Hos","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib28","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1167\/iovs.17-22904","article-title":"Photodynamic therapy leads to time-dependent regression of pathologic corneal (lymph) angiogenesis and promotes high-risk corneal allograft survival","volume":"58","author":"Hou","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib29","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1111\/ajt.14874","article-title":"UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival","volume":"18","author":"Hou","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.exer.2025.110652_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep39924","article-title":"Impaired function of peripherally induced regulatory T cells in hosts at high risk of graft rejection","volume":"6","author":"Inomata","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110652_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13046-016-0451-7","article-title":"Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma","volume":"35","author":"Kim","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.exer.2025.110652_bib32","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110652_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/178132","article-title":"Treatment of corneal neovascularization using anti-VEGF bevacizumab","volume":"2014","author":"Krizova","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110652_bib34","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/s41598-020-60705-z","article-title":"Supplemental anti vegf A-therapy prevents rebound neovascularisation after fine needle diathermy treatment to regress pathological corneal (LYMPH)angiogenesis","volume":"10","author":"Le","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110652_bib35","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41598-018-24037-3","article-title":"Fine needle-diathermy regresses pathological corneal (Lymph)Angiogenesis and promotes high-risk corneal transplant survival","volume":"8","author":"Le","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110652_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10456-016-9515-8","article-title":"Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes","volume":"19","author":"MacDonald","year":"2016","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2025.110652_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00262-007-0441-x","article-title":"The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients","volume":"57","author":"Osada","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.exer.2025.110652_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2025.110652_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1210765","article-title":"Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns","volume":"10","author":"Peng","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.exer.2025.110652_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2025.110652_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4274\/tjo.20270","article-title":"The effects of anti-vascular endothelial growth factor drugs on retinal pigment epithelial cell culture","volume":"48","author":"\u015eahiner","year":"2018","journal-title":"Tjo"},{"key":"10.1016\/j.exer.2025.110652_bib42","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/ajt.15331","article-title":"Local VEGF-A blockade modulates the microenvironment of the corneal graft bed","volume":"19","author":"Salabarria","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.exer.2025.110652_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2015.02.012","article-title":"Corneal angiography for Guiding and evaluating fine-needle diathermy treatment of corneal neovascularization","volume":"122","author":"Spiteri","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110652_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1756-8722-5-63","article-title":"Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy","volume":"5","author":"Sun","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.exer.2025.110652_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00262-016-1941-3","article-title":"Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma","volume":"66","author":"Thomas","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.exer.2025.110652_bib46","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41433-020-01347-3","article-title":"Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study","volume":"35","author":"Ucgul","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.exer.2025.110652_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/ph16070939","article-title":"Comparison of bevacizumab and aflibercept for suppression of angiogenesis in human retinal microvascular endothelial cells","volume":"16","author":"Yazdanyar","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.exer.2025.110652_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017178","article-title":"Clinical characteristics and current treatment of age-related macular Degeneration","volume":"5","author":"Yonekawa","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.exer.2025.110652_bib49","article-title":"Ability to bind Fc-Receptors on Retinal Pigment epithelium (RPE) can explain the higher occurrence of RPE tears with bevacizumab (Avastin\u00ae) compared with ranibizumab (Lucentis\u00ae)","volume":"51","author":"Zeng","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110652_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.11.5.6","article-title":"Posttransplant VEGFR1R2 trap eye drops inhibit corneal (Lymph)angiogenesis and improve corneal allograft survival in eyes at high risk of rejection","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110652_bib51","article-title":"Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival","author":"Zhang","year":"2021","journal-title":"Br. J. Ophthalmol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525004245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525004245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:03:20Z","timestamp":1780722200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525004245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"alternative-id":["S0014483525004245"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110652","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promotion of vessel regression by local VEGF-A blockade improves the survival rate of corneal transplants","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110652"}}